Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intravenous doses of eight antiacetylcholine drugs reduced gastric acid secretion in the rat and caused pupil dilatation in the mouse. Inhibition by these drugs of oxotremorine-induced
hypothermia
in mice was also assessed. The ratio, ED50 (pupil dilatation)/ED50 (gastric acid inhibition), was greater (more favourable) for pirenzepine and oxyphencyclimine than for atropine, benzhexol, glycopyrronium, isopropamide, poldine or propantheline. However, oxyphencyclimine antagonised central oxotremorine activity at all doses having more gastric inhibitory activity.
Pirenzepine
is a peripheral antiacetylcholine drug more selective for reducing gastric acid secretion than for increasing pupil diameter and with little central antiacetylcholine effect.
...
PMID:Pirenzepine selectively inhibits gastric acid secretion: a comparative pharmacological study between pirenzepine and seven other antiacetylcholine drugs. 611 81
Pirenzepine
, (5,11-dihydro-11-[(4-methylpiperazin-1-yl)-acetyl]-6H-pyrido-[2,3] [1,4]-benzodiazepin-6-one dihydrochloride), tested on rats and mice, did not demonstrate any conspicuous behavioral action: it did not counteract reserpine
hypothermia
in mice, the L-DOPA hypermotility of mice, and (with the exception of very large doses) the amphetamine hypermotility in mice and rats. The drug neither prolonged the time of immobility of rats in the behavioral despair test, nor affected the central serotonin system in rats in tests for 5-hydroxytryptophan-induced head twitches, tryptamine-induced convulsions and fenfluramine-induced hyperthermia at high ambient temperature.
Pirenzepine
did not affect either the hind limb flexor reflex in the spinal rat, nor the action of serotoninomimetics of it. The investigated compound had strong peripheral cholinolytic action as it inhibited salivation and lacrimation in the oxotremorine test. The oxotremorine tremor was weakened only by very high doses of pirenzepine. LD50 of the drug in mice was 412 mg/kg ip.
...
PMID:Central action of pirenzepine. 689 18
The potency of centrally administered non-selective (atropine and N-methyl scopolamine) and putatively selective muscarinic antagonists (pirenzepine, AF-DX 116 and 4-DAMP) in inhibition of oxotremorine-induced
hypothermia
, tremor and salivation in male mice has been compared with their potency in vitro in three functional systems, where muscarinic effects are mediated preferentially by M1 (i.e. superior cervical ganglion), M2 (i.e. atrium), and M3 (i.e. ileum) receptors. Atropine, N-methyl scopolamine and 4-DAMP potently abolished the effects of oxotremorine.
Pirenzepine
abolished tremor and salivation, whereas
hypothermia
was antagonized partially only. AF-DX 116 had but weak antagonistic effects. Atropine and N-methyl scopolamine were potent antagonists in all three in vitro test systems. High potency was also seen with 4-DAMP, in particular in the ileum preparation.
Pirenzepine
showed its highest potency in the ganglion preparation. AF-DX 116 was a weak and non-selective antagonist in all three in vitro preparations. Our studies indicate that the muscarinic induction of tremor and salivation may be preferentially mediated by M3 receptors whereas both M2 and M3 receptors may be involved in the mediation of
hypothermia
. However, the overall conclusion is that compounds with higher receptor subtype selectivity are needed.
...
PMID:The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice. 815 35
Choline (75-300 microg) produced dose-dependent
hypothermia
when injected intracerebroventricularly (i.c.v.). Pre-treatment with the muscarinic receptor antagonist, atropine (10 microg, i.c.v.), blocked the hypothermic effect of choline (150 microg), but the response was only partially attenuated by pre-treatment with the nicotinic receptor antagonist, mecamylamine (20 microg, i.c.v.).
Pirenzepine
(25 microg), a muscarinic M1 receptor antagonist, or hexahydro-siladifenidol (HHSD) (100 microg), a muscarinic M3 receptor antagonist, also blocked choline-induced
hypothermia
when injected centrally. Unlike the other muscarinic receptor antagonists, M2-selective 11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyri do[2,3-b][1,4]benzodiazepin-6-one (AF-DX116) (10 microg), did not affect choline-induced
hypothermia
. We also found that choline-induced
hypothermia
was very sensitive to the ambient temperature. Similar to its effect at room temperature, choline produced dose-dependent
hypothermia
at 4 degrees C, but this effect was abolished at 32 degrees C. These data suggest that choline produces
hypothermia
and this effect is mediated by muscarinic receptors.
...
PMID:The effects of choline on body temperature in conscious rats. 988 77